The Centers for Medicare & Medicaid Services’ (CMS’) final rule advances policies to promote the efficient operation of the Medicaid Drug Rebate Program (MDRP).
Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Final Rule
Newsroom Homepage
Listing of Newsroom articles
Fact Sheets
Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Proposed Rule (CMS 1793-P)
On July 7, 2023, in light of the Supreme Court’s decision in American Hospital Association v. Becerra (142 S. Ct. 1896 (2022)) and the district court’s remand to the agency, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule outlining the proposed remedy for the 340B-acquired Read more about Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Proposed Rule (CMS 1793-P)
Fact Sheets
Short-Term, Limited-Duration Insurance; Independent, Noncoordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P)
On July 7, 2023, the Department of Health and Human Services (HHS), the Department of Labor, and the Department of the Treasury (collectively, the Departments) released a notice of proposed rulemaking (NPRM). This NPRM proposes to modify the definition of short-term, limited-duration insurance Read more about Short-Term, Limited-Duration Insurance; Independent, Noncoordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P)
Press Releases
Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following the Food and Drug Administration’s (FDA) move to grant traditional approval to the drug that treats individuals with Alzheimer’s disease. The Centers for Medicare & Medicaid Services Read more about Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
CMS Round Up
CMS Roundup (June 30, 2023)
Today, the Centers for Medicare & Medicaid Services (CMS) is providing an at-a-glance summary of news from around the agency. IRA Extends Insulin Cost Caps to Medicare Part B and Medicare Advantage Starting July 1 Starting July 1, people with Medicare Part B and Medicare Advantage coverage who get Read more about CMS Roundup (June 30, 2023)
Press Releases
CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
For the first time, Medicare will negotiate prices directly with drug companies on behalf of people with Medicare, improving affordability for some of the costliest prescription drugs Read more about CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
Fact Sheets